BioSpace News Archive

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, issued a Letter to Shareholders from the Company’s Chief Executive Officer, Pnina Fishman, Ph.D.

AstraZeneca announced the US Food and Drug Administration has accepted a supplemental New Drug Application and granted Priority Review for FARXIGA® to reduce the risk of cardiovascular death or the worsening of heart failure in adults with heart failure with reduced ejection fraction with and without type 2 diabetes.

Alnylam Pharmaceuticals, Inc. announced that management will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 10:30 am PT at The Westin St. Francis in San Francisco.

Brooks Automation, Inc. announced that company management will participate in the 22nd Annual Needham Growth Conference at the Lotte New York Palace hotel.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, announced the appointment of Kirsten Flowers as Chief Commercial Officer.

The PROOF trial, a Phase 3 trial of infigratinib in first-line cholangiocarcinoma, is currently enrolling

Management will be hosting meetings at the LifeSci Advisors Corporate Access Event in San Francisco during the week

Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to PRGN-3006, a first-in-class investigational therapy using Precigen’s non-viral UltraCAR-T™ therapeutic platform

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the appointment of James Hassard to the newly-created position of chief commercial officer.

BeyondSpring Inc. announced the appointment of Dr. James Tonra, Ph.D. as Chief Science Officer, effective immediately. Dr. Tonra had previously served as Senior Vice President, Preclinical Development at BeyondSpring since April 2018.